NCT02403544 - Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

December 31, 2016

Conditions

Carcinoma, Hepatocellular

Interventions

RADIATION

IGRT

IGRT: 45 to 54Gy, 1.8-3Gy per fraction.

DRUG

Capecitabine

Capecitabine: by oral, D1-14, every 21 days, 600mg/m2 bid per day in level 1, and then escalated every another dose level.

DRUG

Oxaliplatin

Oxaliplatin: intravenously, D1 and D8, every 21 days, 30mg/m2 per day in level 1, and then escalated every another dose level.

Trial Locations (1)

RECRUITING

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing